Global

Personalised Cancer Vaccines Show Longer-Term Staying Power

A new Lp(a) threshold could reshape cardiovascular risk assessment

The next cardiometabolic battleground is ultra-processed food

ADA 2026 findings show diabetes drugs are no longer just chasing glucose

Oral SERDs Face the Hard Test: Where Do They Actually Fit?

Prostate Cancer Value Starts Counting Cognition

China’s PD-1/VEGF Bet Challenges the Lung Cancer Backbone

The ASCO Drug Race Still Runs Through Genomic Testing

High-Risk Prostate Cancer Moves Before the Metastatic Clock Starts
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
